Free Trial

ASR Vermogensbeheer N.V. Buys Shares of 2,403 Celestica, Inc. $CLS

Celestica logo with Computer and Technology background

Key Points

  • ASR Vermogensbeheer N.V. purchased 2,403 shares of Celestica, Inc. valued at approximately $375,000 during the second quarter.
  • Celestica reported a quarterly EPS of $1.39, exceeding analysts' expectations, and achieved a 21% year-over-year revenue growth to $2.89 billion.
  • Wall Street analysts maintain a consensus rating of "Moderate Buy" for Celestica with an average target price of $207.38.
  • Five stocks we like better than Celestica.

ASR Vermogensbeheer N.V. bought a new stake in Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,403 shares of the technology company's stock, valued at approximately $375,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. ST Germain D J Co. Inc. bought a new position in Celestica in the second quarter valued at about $37,000. Wolff Wiese Magana LLC grew its position in Celestica by 45.6% in the second quarter. Wolff Wiese Magana LLC now owns 364 shares of the technology company's stock valued at $57,000 after acquiring an additional 114 shares during the last quarter. ORG Partners LLC bought a new position in Celestica in the first quarter valued at about $29,000. Center for Financial Planning Inc. bought a new position in Celestica in the first quarter valued at about $30,000. Finally, Oakworth Capital Inc. bought a new position in Celestica in the second quarter valued at about $73,000. Institutional investors own 67.38% of the company's stock.

Celestica Price Performance

Celestica stock opened at $234.08 on Friday. The stock's 50 day moving average is $219.11 and its 200 day moving average is $151.41. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.44 and a quick ratio of 0.86. The firm has a market cap of $26.93 billion, a P/E ratio of 50.67 and a beta of 1.88. Celestica, Inc. has a one year low of $52.25 and a one year high of $261.83.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last posted its quarterly earnings data on Monday, July 28th. The technology company reported $1.39 EPS for the quarter, topping analysts' consensus estimates of $1.23 by $0.16. The company had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.65 billion. Celestica had a return on equity of 28.23% and a net margin of 5.11%.The firm's quarterly revenue was up 21.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.91 earnings per share. Celestica has set its Q3 2025 guidance at 1.370-1.530 EPS. FY 2025 guidance at 5.500-5.500 EPS. As a group, research analysts expect that Celestica, Inc. will post 4.35 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CLS. UBS Group reiterated a "neutral" rating and issued a $208.00 target price (up previously from $101.00) on shares of Celestica in a research report on Wednesday, July 30th. Barclays boosted their price target on Celestica from $146.00 to $220.00 and gave the stock an "overweight" rating in a report on Wednesday, July 30th. TD Cowen restated a "hold" rating and set a $238.00 price target on shares of Celestica in a report on Friday. JPMorgan Chase & Co. boosted their price target on Celestica from $225.00 to $295.00 and gave the stock an "overweight" rating in a report on Monday, September 8th. Finally, CICC Research initiated coverage on Celestica in a report on Tuesday, August 19th. They set an "outperform" rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $207.38.

Check Out Our Latest Research Report on CLS

Celestica Profile

(Free Report)

Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.

Further Reading

Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS.

Institutional Ownership by Quarter for Celestica (NYSE:CLS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Celestica Right Now?

Before you consider Celestica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.

While Celestica currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.